Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko
Jun 6 2024
Length: 15 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

Listen for free

View show details

Summary
We love to hear from our listeners. Send us a message.
Elixirgen Therapeutics' Aki Ko joins Erin Harris to detail the company's Bobcat mRNA therapeutic and how it differs from traditional exon-skipping drugs and AAV-microdystrophin in treating DMD. Regarding delivery, Ko explains the advantage of the mRNA approach over the AAV approach.

Show more Show less

Biological Sciences

Show more Show less

What listeners say about Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon